000538.SHE · Yunnan Baiyao Group Co.,Ltd

-

Please sign in to comment on 000538.SHE

1 Comment

Admin

5 years ago

Yunnan Baiyao Group Co.,Ltd is currently in a long term downtrend where the price is trading 6.7% below its 200 day moving average.

From a valuation standpoint, the stock is 50.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.

Yunnan Baiyao Group Co.,Ltd's total revenue rose by 9.9% to $9B since the same quarter in the previous year.

Its net income has increased by 96.8% to $1B since the same quarter in the previous year.

Finally, its free cash flow fell by 89.2% to $192M since the same quarter in the previous year.

Based on the above factors, Yunnan Baiyao Group Co.,Ltd gets an overall score of 3/5.

Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Exchange	SHE
CurrencyCode	CNY
ISIN	CNE0000008X7

Market Cap	98B
PE Ratio	18.97
Target Price	69.845
Beta	0.27
Dividend Yield	2.9%

ABOUT

Yunnan Baiyao Group Co.,Ltd

Yunnan Baiyao Group Co.,Ltd engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China. The company offers health products; traditional Chinese medicine used for pain management and anti-inflammation, including the Yunnan Baiyao aerosol, Yunnan Baiyao ointment, and Yunnan Baiyao band-aid; generic drugs and natural specialty medicines in various areas, such as physical fitness, respiratory ailments, cardiovascular health, gynecology, pediatrics, and others; medical devices; tea products; and pharmaceutical supply chain service solutions. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

000538.SHE · Yunnan Baiyao Group Co.,Ltd

-

Yunnan Baiyao Group Co.,Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Yunnan Baiyao Group Co.,Ltd using a moving average strategy